Internal medicine, Nuclear medicine, Positron emission tomography, Blood flow and Cardiology are his primary areas of study. His research on Internal medicine frequently links to adjacent areas such as Endocrinology. His biological study spans a wide range of topics, including Tomography, Carbon-11 acetate, Deoxyglucose and Metabolism.
His research investigates the link between Positron emission tomography and topics such as Perfusion that cross with problems in Adenoviridae and Ex vivo. His Blood flow study incorporates themes from Hemodynamics, Circulatory system, Stenosis and Ammonia. His Coronary artery disease research includes themes of Ventricle, Radiology and Heart failure.
Heinrich R. Schelbert mainly focuses on Internal medicine, Cardiology, Blood flow, Nuclear medicine and Positron emission tomography. His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. His work in the fields of Cardiology, such as Coronary artery disease, Perfusion, Ejection fraction and Myocardial infarction, overlaps with other areas such as In patient.
His study looks at the relationship between Blood flow and topics such as Hemodynamics, which overlap with Fissipedia and Heart rate. The concepts of his Nuclear medicine study are interwoven with issues in Tomography, Carbohydrate metabolism and Biomedical engineering. His research in Positron emission tomography intersects with topics in Single-photon emission computed tomography, Medical physics, Cardiomyopathy and Revascularization.
Heinrich R. Schelbert focuses on Internal medicine, Cardiology, Blood flow, Coronary artery disease and Nuclear medicine. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus, Endocrinology and Type 2 Diabetes Mellitus. The various areas that Heinrich R. Schelbert examines in his Blood flow study include Pathophysiology, Dobutamine and Intensive care medicine.
His work carried out in the field of Coronary artery disease brings together such families of science as Positron emission tomography, Fractional flow reserve and Endothelium. His research integrates issues of Magnetic resonance imaging, Single-photon emission computed tomography, Medical physics and Tomography in his study of Positron emission tomography. His studies in Nuclear medicine integrate themes in fields like CAD and Medical imaging.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron Tomography
Jan Tillisch;Richard Brunken;Robert Marshall;Markus Schwaiger.
The New England Journal of Medicine (1986)
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
Marcelo F. Di Carli;Michael Davidson;Roderick Little;Sandeep Khanna.
American Journal of Cardiology (1994)
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging
Gary D. Hutchins;Markus Schwaiger;Karen C. Rosenspire;Janine Krivokapich.
Journal of the American College of Cardiology (1990)
Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart
Michael E. Phelps;John C. Mazziotta;Heinrich R. Schelbert.
N-13 ammonia as an indicator of myocardial blood flow.
H R Schelbert;M E Phelps;S C Huang;N S MacDonald.
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
K. Lance Gould;Nils P. Johnson;Timothy M. Bateman;Rob S. Beanlands.
Journal of the American College of Cardiology (2013)
Influence of age and hemodynamics on myocardial blood flow and flow reserve.
J. Czernin;P. Müller;Sammy Chan;R. C. Brunken.
Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
Robert C. Marshall;Jan H. Tillisch;Michael E. Phelps;Sung-cheng Huang.
Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs.
K. Lance Gould;Heinrich R. Schelbert;Michael E. Phelps;Edward J. Hoffman.
American Journal of Cardiology (1978)
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Johannes Czernin;Martin Allen-Auerbach;Heinrich R. Schelbert.
The Journal of Nuclear Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: